National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. NICE, 2008.
Brooks, R. EuroQol: the current state of play. Health Policy
1996; 37: 53–72.
Dolan, P. Modeling valuations for EuroQol health states. Med Care
1997; 35: 1095–108.
Brazier, J, Roberts, J, Deverill, M. The estimation of a preference-based measure of health from the SF-36. J Health Econ
2002; 21: 271–92.
Brazier, JE, Roberts, J. Estimating a preference-based index from the SF-12. Med Care
2004; 42: 851–9.
Brazier, J. Measuring and valuing mental health for economic evaluation. J Health Serv Res Policy
2008; 13 (suppl 3): 70–5.
Brazier, J. Is the EQ-5D fit for purpose in mental health?
Br J Psychiatry
2010; 197: 348–9.
Lamers, LM, Bouwmans, CA, van Straten, A, Donker, MC, Hakkaart, L. Comparison of EQ-5D and SF-6D utilities in mental health. Health Econ
2006; 15: 1229–36.
Papaioannou, D, Brazier, J, Parry, G. How valid and responsive are generic health status measures, such as EQ-5D and SF-6D, in schizophrenia? A systematic review. Value Health
2011; 14: 907–20.
Barton, GR, Hodgekins, J, Mugford, M, Jones, PB, Croudace, T, Fowler, D. Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D. Br J Psychiatry
2009; 195: 170–7.
Soeteman, DI, Timman, R, Trijsburg, RW, Verheul, R, Busschbach, JVV. Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. Psychiatr Serv
2005; 56: 1153–5.
Soeteman, DI, Verheul, R, Delimon, J, Meerman, AMMA, van den Eijnden, E, Rossum, BV, et al. Cost-effectiveness of psychotherapy for cluster B personality disorders. Br J Psychiatry
2010; 196: 396–403.
Brazier, JE, Connell, J, Papaioannou, D, Mukuria, C, Mulhern, B, O'Cathain, A, et al. Validating generic preference-based measures of health in mental health populations and estimating mapping functions for widely used specific measures. In Health Technol Assess
Kendrick, T, Peveler, R, Longworth, L, Baldwin, D, Moore, M, Chatwin, J, et al. Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial. Br J Psychiatry
2006; 188: 337–45.
Morrell, CJ, Slade, P, Warner, R, Paley, G, Dixon, S, Walters, SJ, et al. Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. BMJ
2009; 338: a3045.
Mukuria, C, Brazier, J, Barkham, M, Connell, J, Hardy, G, Hutten, R, et al. Cost-effectiveness of an Improving Access to Psychological Therapies service. Br J Psychiatry
2013; 202: 220–7.
Byford, S, Knapp, M, Greenshields, J, Ukoumunne, OC, Jones, V, Thompson, S, et al. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a rational decision making approach. Psychol Med
2003; 33: 977–86.
Tyrer, P, Tom, B, Byford, S, Schmidt, U, Jones, V, Davidson, K, et al. Differential effects of manual assisted cognitive behavior therapy in the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Pers Disord
2004; 18: 102–16.
Gray, R, Leese, M, Bindman, J, Becker, T, Burti, L, David, A, et al. Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br J Psychiatry
2006; 189: 508–14.
Crawford, MJ, Kilaspy, H, Barnes, TRE, Barrett, B, Byford, S, Clayton, K. Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial. In BMJ
2012: 344: e846.
Soeteman, D, Verheul, R, Busschbach, J. The burden of disease in personality disorders: diagnosis-specific quality of life. J Pers Disord
2008; 22: 259–68.
Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies: Canada (3rd edn). Canadian Agency for Drugs and Technologies in Health, 2006.
Pharmaceutical Benefits Advisory Committee. Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC). Commonwealth of Australia, 2008.
Zigmond, AS, Snaith, RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand
1993; 67: 361–70.
Bjelland, I, Dahl, AA, Haug, TT, Neckelmann, D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res
2002; 52: 69–77.
Barkham, M, Evans, C, Margison, F, McGrath, G, Mellor-Clark, J, Connell, J, et al. The rationale for developing and implementing core batteries for routine use in service settings and psychotherapy outcome research. J Ment Health
1998; 7: 35–47.
Barkham, M, Gilbert, N, Connell, J, Marshall, C, Twigg, E. Suitability and utility of the CORE-OM and CORE-A for assessing severity of presenting problems in psychological therapy services based in primary and secondary care settings. Br J Psychiatry
2005; 186: 239–46.
Evans, C, Mellor-Clark, J, Margison, F, Barkham, M, Audin, K, Connell, J, et al. CORE: Clinical Outcomes in Routine Evaluation. J Ment Health
2000; 9: 247–55.
Evans, C, Connell, J, Barkham, M, Margison, F, McGrath, G, Mellor-Clark, J, et al. Towards a standardised brief outcome measure: psychometric properties and utility of the CORE-OM. Br J Psychiatry
2002; 180: 51–60.
Gilbody, S, Richards, D, Barkham, M. Diagnosing depression in primary care using self-completed instruments: UK validations of PHQ-9 and CORE-OM. Br J Gen Pract
2007; 57: 650–2.
Pfohl, B, Blum, N, Zimmerman, M. Structured Interview for DSM-IV Personality: SIDP-IV. American Psychiatric Press, 1995.
Ventura, J, Lukoff, D, Nuechterlein, K, Liberman, R, Green, M, Shaner, A. Brief Psychiatric Rating Scale (BPRS) Expanded Version (4.0) scales, anchor points and administration manual. Int J Methods Psychiatr Res
1993; 3: 227–43.
Kay, SR, Fiszbein, A, Opler, LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull
1987; 13: 261–76.
Cleveland, WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc
1979; 74: 829–36.
Leucht, S, Kane, JM, Kissling, W, Hamann, J, Etschel, E, Engel, R. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry
2005; 187: 366–71.
Leucht, S, Kane, JM, Kissling, W, Hamann, J, Etschel, E, Engel, RR. What does the PANSS mean?
2005; 79: 231–8.
Cohen, J. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Erlbaum, 1988.
Connell, J, Brazier, J, O'Cathain, A, Lloyd-Jones, M, Paisley, S. Quality of life of people with mental health problems: a synthesis of qualitative research. Health Qual Life Outcomes
2012; 10: 138.
Herdman, M, Gudex, C, Lloyd, A, Janssen, M, Kind, P, Parkin, D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res
2011; 20: 1727–36.
Mavranezouli, I, Brazier, J, Young, T, Barkham, M. Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems. Qual Life Res
2011; 20: 321–33.